187 related articles for article (PubMed ID: 32884006)
1. Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line.
Monazzam A; Li SC; Wargelius H; Razmara M; Bajic D; Mi J; Bergquist J; Crona J; Skogseid B
Sci Rep; 2020 Sep; 10(1):14572. PubMed ID: 32884006
[TBL] [Abstract][Full Text] [Related]
2. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
3. The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms.
He L; Boulant S; Stanifer M; Guo C; Nießen A; Chen M; Felix K; Bergmann F; Strobel O; Schimmack S
Cancer Sci; 2022 May; 113(5):1575-1586. PubMed ID: 35179814
[TBL] [Abstract][Full Text] [Related]
4. Two well-differentiated pancreatic neuroendocrine tumor mouse models.
Wong C; Tang LH; Davidson C; Vosburgh E; Chen W; Foran DJ; Notterman DA; Levine AJ; Xu EY
Cell Death Differ; 2020 Jan; 27(1):269-283. PubMed ID: 31160716
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
Marini F; Giusti F; Tonelli F; Brandi ML
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
[TBL] [Abstract][Full Text] [Related]
6. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.
Görtz B; Roth J; Krähenmann A; de Krijger RR; Muletta-Feurer S; Rütimann K; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
Am J Pathol; 1999 Feb; 154(2):429-36. PubMed ID: 10027401
[TBL] [Abstract][Full Text] [Related]
7. Expression of p27
Conemans EB; Raicu-Ionita GM; Pieterman CRC; Dreijerink KMA; Dekkers OM; Hermus AR; de Herder WW; Drent ML; van der Horst-Schrivers ANA; Havekes B; Bisschop PH; Offerhaus GJ; Borel Rinkes IHM; Valk GD; Timmers HTM; Vriens MR
J Endocrinol Invest; 2018 Jun; 41(6):655-661. PubMed ID: 29134609
[TBL] [Abstract][Full Text] [Related]
8. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.
Lin W; Watanabe H; Peng S; Francis JM; Kaplan N; Pedamallu CS; Ramachandran A; Agoston A; Bass AJ; Meyerson M
Mol Cancer Res; 2015 Apr; 13(4):689-98. PubMed ID: 25537453
[TBL] [Abstract][Full Text] [Related]
9. Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/Jif-1.
Stålberg P; Grimfjärd P; Santesson M; Zhou Y; Lindberg D; Gobl A; Oberg K; Westin G; Rastad J; Wang S; Skogseid B
J Clin Endocrinol Metab; 2004 May; 89(5):2326-37. PubMed ID: 15126560
[TBL] [Abstract][Full Text] [Related]
10. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.
Hamze Z; Vercherat C; Bernigaud-Lacheretz A; Bazzi W; Bonnavion R; Lu J; Calender A; Pouponnot C; Bertolino P; Roche C; Stein R; Scoazec JY; Zhang CX; Cordier-Bussat M
Endocr Relat Cancer; 2013 Dec; 20(6):833-48. PubMed ID: 24157940
[TBL] [Abstract][Full Text] [Related]
11. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.
Shen HC; He M; Powell A; Adem A; Lorang D; Heller C; Grover AC; Ylaya K; Hewitt SM; Marx SJ; Spiegel AM; Libutti SK
Cancer Res; 2009 Mar; 69(5):1858-66. PubMed ID: 19208834
[TBL] [Abstract][Full Text] [Related]
12. Clinically Defined Mutations in
Duan S; Sheriff S; Elvis-Offiah UB; Witten BL; Sawyer TW; Sundaresan S; Cierpicki T; Grembecka J; Merchant JL
Cancer Res Commun; 2023 Jul; 3(7):1318-1334. PubMed ID: 37492626
[TBL] [Abstract][Full Text] [Related]
13. Progranulin Stimulates Proliferation of Mouse Pancreatic Islet Cells and Is Overexpressed in the Endocrine Pancreatic Tissue of an MEN1 Mouse Model.
Barbu A; Lejonklou MH; Skogseid B
Pancreas; 2016 Apr; 45(4):533-40. PubMed ID: 26495792
[TBL] [Abstract][Full Text] [Related]
14. Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
Walls GV; Reed AA; Jeyabalan J; Javid M; Hill NR; Harding B; Thakker RV
Endocrinology; 2012 Nov; 153(11):5167-79. PubMed ID: 23024266
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
16. MENIN-mediated regulation of gastrin gene expression and its role in gastrinoma development.
Elvis-Offiah UB; Duan S; Merchant JL
FASEB J; 2023 May; 37(5):e22913. PubMed ID: 37078545
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization.
Capodanno Y; Chen Y; Schrader J; Tomosugi M; Sumi S; Yokoyama A; Hiraoka N; Ohki R
Neoplasia; 2021 Sep; 23(9):979-992. PubMed ID: 34352404
[TBL] [Abstract][Full Text] [Related]
18. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
[TBL] [Abstract][Full Text] [Related]
19. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
20. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
Marini F; Brandi ML
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
